<b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease Post author:Sam Post published:June 25, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Bionik Laboratories Corp. Issues Letter To Shareholders August 21, 2017 Celgene ReleaseData Presented At 2017 Further Evaluate Role Of ABRAXANE For Patients With Historically Challenging Cancers September 7, 2017 Immutep Strikes Deal with Merck to Pair Product With Keytruda in Phase II Trial March 11, 2018
Celgene ReleaseData Presented At 2017 Further Evaluate Role Of ABRAXANE For Patients With Historically Challenging Cancers September 7, 2017